Calcium phosphate cements as bone drug delivery systems: A review

Journal of Controlled Release

Volumn 113, Issue 2, 2006, Pages 102-110

  Ginebra, M P ^a   Traykova, T ^a   Planell, J A ^a  

^a Biomedical Engineering Research Center CREB   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BIOMEDICAL ENGINEERING; BONE; CONTROLLED DRUG DELIVERY; GROWTH KINETICS; PHOSPHATES; THERMAL EFFECTS;

ANTI-INFLAMMATORY; BONE DRUG DELIVERY SYSTEMS; CALCIUM PHOSPHATE CEMENTS;

CALCIUM COMPOUNDS;

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; APATITE; BONE CEMENT; BOVINE SERUM ALBUMIN; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE DIBASIC; DRUG CARRIER; ESTRADIOL; GENTAMICIN BONE CEMENT; INDOMETACIN; INSULIN; MERCAPTOPURINE; NANOPARTICLE; POLY(METHYL METHACRYLATE); POLYACRYLIC ACID; POLYGLACTIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SALICYLIC ACID; VANCOMYCIN;

BIOCOMPATIBILITY; BODY FLUID; BONE MASS; BONE MINERALIZATION; BONE REGENERATION; CONTROLLED DRUG RELEASE; DIFFUSION COEFFICIENT; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG MECHANISM; DRUG RELEASE; DRUG SOLUBILITY; INFECTION PREVENTION; MATHEMATICAL ANALYSIS; MECHANICAL STRESS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OSTEOMYELITIS; OSTEOPOROSIS; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; PROSTHESIS INFECTION; REVIEW; SURGICAL INFECTION; WOUND INFECTION;

ANIMALS; BONE CEMENTS; BONE DISEASES; CALCIUM PHOSPHATES; DRUG DELIVERY SYSTEMS; HUMANS;

EID: 33746972807     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2006.04.007     Document Type: Review

References (70)

1. National Osteoporosis Foundation. Physician's Guide to Prevention and Treatment of Osteoporosis (1998), Exempta Medica, Belle Mead, NJ
2. Arkfield D.G., and Rubenstein E. Quest for the holy grial to cure arthritis and osteoporosis: emphasis on bone drug delivery systems. Adv. Drug Deliv. Rev. 57 (2005) 934-944
3. Tiselius A., Hjerten S., and Levin O. Protein chromatography on calcium phosphate columns. Arch. Biochem. Biophys. 65 (1956) 132-136
4. Urist M.R., Huo Y.K., Brownell A.G., Hohl W.M., Buyske J., Lietze A., Tempst P., Hunkapiller M., and DeLange R.J. Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc. Natl. Acad. Sci. 81 (1984) 371-375
5. LeGeros R., Chohayeb A., and Shulman A. Apatitic calcium phosphates: possible dental restorative materials. J. Dent. Res. 61 (1982) 343
6. Brown W.E., and Chow L.C. A new calcium phosphate setting cement. J. Dent. Res. 62 (1983) 672
7. Driessens F.C.M., Boltong M.G., Khairoun I., De Maeyer E.A.P., Ginebra M.P., Wenz R., Planell J.A., and Verbeeck R.M.H. Applied aspects of calcium phosphate bone cement. In: Wise D.L., Trantolo D.J., Lewandrowski K.U., Gresser J.D., and Cattaneo M.V. (Eds). Biomaterials Engineering and Devices: Human Applications. Vol. 2: Orthopaedic, Dental and Bone Graft Applications (2000), Humana Press, Totowa, NJ 253-260
8. Bohner M., Gbureck U., and Barralet J.E. Technological issues for the development of more efficient calcium phosphate bone cements: a critical assessment. Biomaterials 26 (2005) 6423-6429
9. Tofighi A., Mounic S., Chakravarthy P., Rey C., and Lee D. Setting reactions involved in injectable cements based on amorphous calcium phosphate. Key Eng. Mater. 192-195 (2000) 769-772
10. Constantz B., et al. Skeletal repair by in situ formation of the mineral phase of bone. Science 267 (1995) 1796-1799
11. M. Freche, J.L. Lacout, Z. Hatim, 1999. Method for preparing a biomaterial based on hydroxyapatite, resulting biomaterial and surgical or dental use. FR Patent No. 2776282.
12. Driessens F.C.M., Boltong M.G., Bermudez O., Ginebra M.P., Fernández E., and Planell J.A. Effective formulations for the preparation of calcium phosphate bone cements. J. Mater. Sci., Mater. Med. 5 (1994) 164-170
13. Ginebra M.P., Fernandez E., De Maeyer E., Verbeeck R.M.H., Boltong M.G., Ginebra J., Driessens F.C.M., and Planell J.A. Setting reaction and hardening of an apatitic calcium phosphate cement. J. Dent. Res. 76 4 (1997) 905-912
14. Ginebra M.P., Boltong M.G., Fernández E., Planell J.A., and Driessens F.C.M. Effect of various additives and of the temperature on some properties of an apatitic calcium phosphate cement. J. Mater. Sci., Mater. Med. 6 (1995) 612-616
15. Ginebra M.P., Driessens F.C.M., and Planell J.A. Effect of the particle size on the micro and nanostructural features of a calcium phosphate cement: a kinetic analysis. Biomaterials 25 (2004) 3453-3462
16. Fernández E., Boltong M.G., Ginebra M.P., Driessens F.C.M., Bermúdez O., and Planell J.A. Development of a method to measure the period of swelling of calcium phosphate cements. J. Mater. Sci. Lett. 15 (1996) 1004-1005
17. 4 addition on the setting reaction kinetics of an α-TCP cement. In: LeGeros R.Z., and LeGeros J.P. (Eds). Proceedings of the 11th International Symposium on Ceramics in Medicine. Bioceramics vol. 11 (1998), World Scientific Publishing Co. Pte. Ltd., Singapore 243-246
18. Kurashina K., et al. In vivo study of calcium phosphate cements: implantation of an α-tricalcium phosphate/dicalcium phosphate dibasic/tetracalcium phosphate monoxide cement paste. Biomaterials 18 (1997) 539-543
19. Apelt D., Theiss F., El-Warrak A.O., Zlinszky K., Bettschart-Wolfisberger R., Bohner M., Matter S., Auer J.A., and Von Rechenberg B. In vivo behavior of three different injectable hydraulic calcium phosphate cements. Biomaterials 25 7-8 (2004) 1439-1451
20. Jansen J.A., de Ruijter J.E., Schaeken H.G., van der Waerden J.P.C., Planell J.A., and Driessens F.C.M. Evaluation of tricalciumphosphate/hydroxyapatite cement for tooth replacement: an experimental animal study. J. Mater. Sci., Mater. Med. 6 (1995) 653-657
21. Friedman C.D., Costantino P.D., Takagi S., and Chow L.C. Bonesource hydroxyapatite cement: a novel biomaterial for cranofacial skeletal tissue engineering and reconstruction. J. Biomed. Mater. Res., Appl. Biomater. 43 (1998) 428-432
22. Larsson S., and Bauer T.W. Use of injectable calcium phosphate cement for fracture fixation: a review. Clin. Orthop. Relat. Res. 395 (2002) 23-32
23. Ooms E.M., Wolke J.G.C., van de Heuvel M.T., Jeschke B., and Jansen J.A. Histological evaluation of the bone response to calcium phosphate cement implanted in cortical bone. Biomaterials 24 6 (2003) 989-1000
24. P. Torner, Bone tissue repair by osteotransduction with a calcium phosphate cement. An experimental study. PhD Thesis from the Dept of Surgery, Faculty of Medicine. Universitat de Barcelona, Barcelona, Spain (2001).
25. In: Mathiowitz E. (Ed). Encyclopaedia of Controlled Drug Delivery (1999), John Wiley and Sons, New York
26. In: Ratner B.D., Hoffman A.S., Schoen F.J., and Lemons J.E. (Eds). Biomaterials Science. An Introduction to Materials in Medicine. 2nd Edition (2004), Academic Press, San Diego, CA
27. Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 52 (1963) 1143-1149
28. Otsuka M., Matsuda Y., Suwa Y., Fox J.L., and Higuchi W.I. A novel skeletal drug delivery system using self-setting calcium phosphate cement 5: drug-release behaviour from a heterogeneous drug-loaded cement containing an anticancer drug. J. Pharm. Sci. 83 11 (1994) 1565-1568
29. Otsuka M., Nakahigashi Y., Matsuda Y., Fox J.L., Higuchi W.I., and Sugiyama Y. Effect of geometrical cement size on in vitro indomethacin release from self-setting apatite cement. J. Control. Release 52 3 (1998) 281-289
30. Otsuka M., Nakahigashi Y., Matsuda Y., Fox J.L., Higuchi W.I., and Sugiyama Y. A novel skeletal drug delivery system using self-setting calcium phosphate cement VIII: the relationship between in vitro and in vivo drug release from indomethacin-containing cement. J. Control. Release 43 2-3 (1997) 115-122
31. Otsuka M., Matsuda Y., Fox J.L., and Higuchi W.I. Novel skeletal drug delivery system using self-setting calcium phosphate cement 9: effects of the mixing solution volume on anticancer drug-release from homogeneous drug-loaded cement. J. Pharm. Sci. 84 6 (1995) 733-736
32. Otsuka M., Matsuda Y., Suwa Y., Fox J.L., and Higuchi W.I. A novel skeletal drug-delivery system using self-setting calcium-phosphate cement 4. Effects of the mixing solution volume on the drug-release rate of heterogeneous aspirin-loaded cement. J. Pharm. Sci. 83 2 (1994) 259-263
33. Bohner M., Lemaitre J., VanLanduyt P., Zambelli P.Y., Merkle H.P., and Gander B. Gentamicin-loaded hydraulic calcium phosphate bone cement as antibiotic delivery system. J. Pharm. Sci. 86 5 (1997) 565-572
34. Bohner M., Lemaitre J., Merckle H.P., and Gander B. Control of gentamicin release from a calcium phosphate admixed poly(acrylic acid). J. Pharm. Sci. 89 10 (2000) 1262-1270
35. Suzuki T., Arai K., Goto H., Hanano M., Watanabe J., and Tomono K. Dissolution tests for self-setting calcium phosphate cement-containing nifedipine. Chem. Pharm. Bull. 50 6 (2002) 741-743
36. Otsuka M., Matsuda Y., Wang Z., Fox J.L., and Higuchi W.I. Effect of sodium bicarbonate amount on in vitro indomethacin release from self-setting carbonated-apatite cement. Pharm. Res. 14 4 (1997) 444-449
37. Tung I.C. In-vitro drug release of antibiotic-loaded porous hydroxyapatite cement. Artif. Cells Blood Substit. Immobil. Biotechnol. 23 1 (1995) 81-88
38. Klemm K. Antibiotic bead chains. Clin. Orthop. 295 (1993) 63-76
39. Peltier L.F., and Jones R.H. Treatment of unicameral bone cysts by curettage and packing with plaster-of-paris pellets. J. Bone Jt. Surg., Am. 60A (1978) 820-822
40. Takechi M., Miyamoto Y., Ishikawa K., Nagayama M., Kon M., Asaoka K., and Suzuki K. Effects of added antibiotics on the basic properties of anti-washout-type fast-setting calcium phosphate cement. J. Biomed. Mater. Res. 39 2 (1998) 308-316
41. Ratier, Gibson I.R., Best S.M., Freche M., Lacout J.L., and Rodriguez F. Behaviour of a calcium phosphate bone cement containing tetracycline hydrochloride or tetracycline complexed with calcium ions. Biomaterials 22 (2001) 897-901
42. Huang Y., Liu C.S., Shao H.F., and Liu Z.J. Study on the applied properties of tobramycin-loaded calcium phosphate cement. Key Eng. Mater. 192-1 (2000) 853-860
43. Hamanishi C., Kitamoto K., Tanaka S., Otsuka M., Doi Y., and Kitahashi T. A self-setting TTCP-DCPD apatite cement for release of vancomycin. J. Biomed. Mater. Res., Appl. Biomater. 33 3 (1996) 139-143
44. Ethell M.T., Bennett R.A., Brown M.P., Merritt K., Davidson J.S., and Tran T. In vitro elution of gentamicin, amikacin and ceftiofur from polymethylmethacrylate and hydroxyapatite cement. Vet. Surg. 29 5 (2000) 375-382
45. Takechi M., Miyamoto Y., Momota Y., Yuasa T., Tatehara S., Nagayama M., Ishikawa K., and Suzuki K. The in vitro antibiotic release from anti-washout apatite cement using chitosan. J. Mater. Sci., Mater. Med. 13 10 (2002) 973-978
46. Stallmann H.P., Faber C., Bronckers A.L.J.J., Amerongen A.V.N., and Wuisman P.I.J.M. Osteomyelitis prevention in rabbits using antimicrobial peptide hLF-11 or gentamicin-containing calcium phosphate cement. J. Antimicrob. Chemother. 54 2 (2004) 472-476
47. Ginebra M.P., Rilliard A., Fernández E., Elvira C., San Román J., and Planell J.A. Mechanical and rheological improvement of a calcium phosphate cement by the addition of a polymeric drug. J. Biomed. Mater. Res. 57 1 (2001) 113-118
48. Otsuka M., Nakahigashi Y., Matsuda Y., Fox J.L., and Higuchi W.I. A novel skeletal drug delivery system using self-setting calcium phosphate cement 7: effect of biological factors on indomethacin release from the cement loaded on bovine bone. J. Pharm. Sci. 83 11 (1994) 1569-1573
49. Kokubo T., Kim H., and Kawashita M. Novel bioactive materials with different mechanical properties. Biomaterials 24 (2003) 2161-2175
50. Otsuka M., Yoneoka K., Matsuda Y., Fox J.L., Higuchi W.I., and Sugiyama Y. Oestradiol release from self-setting apatitic bone cement responsive to plasma-calcium level in ovariectomized rats and its physicochemical mechanism. J. Pharm. Pharmacol. 49 12 (1997) 1182-1188
51. Otsuka M., Matsuda Y., Baig A.A., Chhettry A., and Higuchi W.I. Calcium-level responsive controlled drug delivery from implant dosage forms to treat osteoporosis in an animal model. Adv. Drug Deliv. Rev. 42 (2000) 249-258
52. Nimni M.E. Polypeptide growth factors: targeted delivery systems. Biomaterials 18 (1997) 1201-1225
53. Centrella M., Massague J., and Canalis E. Human platelet-derived transforming growth factor β stimulates parameters of bone growth in fetal rat calvaria. Endocrinology 119 (1986) 2306-2312
54. Noda M., and Camilliere J.J. In vivo stimulation of bone formation by transforming growth factor β. Endocrynology 124 (1989) 2991-2994
55. Bosch C., Melsen B., Gibbons R., and Vargervik K. Human recombinant transforming growth factor beta 1 in healing of calvarial bone defects. Craniofac. Surg. 7 (1996) 300-310
56. Lind M., Overgaard S., Soballe K., Nguyen T., Ongpipattanakul B., and Bunger C. Transforming growth factor-beta 1 enhances bone healing to unloaded tricalcium phosphate coated implants: an experimental study in dogs. J. Orthop. Res. 14 (1996) 343-350
57. 1 incorporated during setting in calcium phosphate cement stimulates bone cell differentiation in vitro. J. Biomed. Mater. Res. 50 (2000) 67-74
58. Blom E.J., Klein-Nulend J., Wolke J.G.C., Kurashina K., van Waas M.A.J., and Burger E.H. Transforming growth factor-beta 1 incorporation in an alpha-tricalcium phosphate/dicalcium phosphate dihydrate/tetracalcium phosphate monoxide cement: release characteristics and physicochemical properties. Biomaterials 23 4 (2002) 1261-1268
59. Blom E.J., Klein-Nulend J., Wolke J.G.C., van Waas M.A.J., Driessens F.C.M., and Burger E.H. Transforming growth factor-beta 1 incorporation in a calcium phosphate bone cement: material properties and release characteristics. J. Biomed. Mater. Res. 59 2 (2002) 265-272
60. 1 in calcium phosphate cement stimulates bone regeneration. J. Dent. Res. 79 (2000) 255
61. Ruhe P.Q., Hedberg E.L., Padron N.T., Spauwen P.H., Jansen J.A., and Mikos A.G. rhBMP-2 release from injectable poly(dl-lactic-co-glycolic acid)/calcium-phosphate cement composites. J. Bone Jt. Surg. 85 (2003) 75-82
62. Lee D.D., Tofighi A., Aiolova M., Chakravarthy P., Catalano A., Majad A., and Knaack D. Alpha-BSM®: a biomimetic bone substitute and drug delivery vehicle. Clin. Orthop. Relat. Res. 367 (1999) S396-S405 (Suppl.)
63. Seeherman H.J., Li R., and Wozney J.M. A review of preclinical program development for evaluating injectable carriers for osteogenic factors. J. Bone Jt. Surg., A 85 (2003) 96-111
64. Edwards III R.B., Seeherman H.J., Bogdanske J.J., Devitt J., Vanderby R., and Markee M.D. Percutaneous injection of recombinant human bone morphogenetic protein-2 in a calcium phosphate paste accelerates healing of a canine tibial osteotomy. J. Bone Jt. Surg., A 86 (2004) 1425-1438
65. Seeherman H.J., Bouxsein M., Kim H., Li R., Li X.J., Aiolova M., and Wozney J.M. Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomy-site healing in a nonhuman primate model. J. Bone Jt. Surg., A 86 (2004) 1961-1973
66. Ohura K., Hamanishi C., Tanaka S., and Matsuda N. Healing of segmental bone defects in rats induced by a β-TCP-MCPM cement combined with rhBMP-2. J. Biomed. Mater. Res. 44 (1999) 168-175
67. Urist M.R., Lietze A., and Dawson E. β-Tricalcium phosphate delivery system for bone morphogenetic protein. Clin. Orthop. 187 (1984) 277-280
68. Kamegai A., Shimamura N., Naitou K., Nagahara K., Kanematsu N., and Mori M. Bone formation under the influence of bone morfogenetic protein/self-setting apatite cement composite as delivery system. Bio-Med. Mater. Eng. 4 (1994) 291-307
69. Knepper-Nicolai B., Reinstorf A., Hofinger I., Flade K., Wenz R., and Pompe W. Influence of osteocalcin and collagen i on the mechanical and biological properties of Biocement D. Biomol. Eng. 19 2-6 (2002) 227-231
70. Otsuka M., Matsuda Y., Suwa Y., Fox J.L., and Higuchi W.I. Novel skeletal drug-delivery system using self-setting calcium phosphate cement. 3. Physicochemical properties and drug-release rate of bovine insulin and bovine albumin. J. Pharm. Sci. 83 (1994) 255-258